These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 29091800)

  • 1. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.
    Oronsky B; Ma PC; Morgensztern D; Carter CA
    Neoplasia; 2017 Dec; 19(12):991-1002. PubMed ID: 29091800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
    Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
    Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
    Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
    Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors.
    Sonbol MB; Halfdanarson TR
    Curr Treat Options Oncol; 2019 Aug; 20(9):74. PubMed ID: 31428952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms.
    Eads JR; Halfdanarson TR; Asmis T; Bellizzi AM; Bergsland EK; Dasari A; El-Haddad G; Frumovitz M; Meyer J; Mittra E; Myrehaug S; Nakakura E; Raj N; Soares HP; Untch B; Vijayvergia N; Chan JA
    Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Tract Large Cell Neuroendocrine Carcinoma: Diagnostic, Prognostic and Therapeutic Issues.
    Sanguedolce F; Calò B; Chirico M; Tortorella S; Carrieri G; Cormio L
    Anticancer Res; 2020 May; 40(5):2439-2447. PubMed ID: 32366387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
    Fazio N; Abdel-Rahman O
    Curr Treat Options Oncol; 2021 Feb; 22(3):19. PubMed ID: 33559013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
    Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
    Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment landscape of advanced high-grade neuroendocrine neoplasms.
    Alheraki SZ; Almquist DR; Starr JS; Halfdanarson TR; Sonbol MB
    Clin Adv Hematol Oncol; 2023 Jan; 21(1):16-26. PubMed ID: 36638352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.
    Waseem N; Aparici CM; Kunz PL
    J Nucl Med; 2019 Jul; 60(7):882-891. PubMed ID: 30850504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Yin F; Wu ZH; Lai JP
    World J Gastroenterol; 2022 May; 28(17):1751-1767. PubMed ID: 35633912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
    Scoazec JY
    Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature.
    Watson GA; Ahmed Y; Picardo S; Chew S; Cobbe S; Mahony C; Crotty J; Wallis F; Shelly MJ; Kiely P; Ipadeola OB; Healy V; Osman N; Gupta RK
    Am J Case Rep; 2018 Jun; 19():710-723. PubMed ID: 29915166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Sigel CS
    Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.